Induction of taxol metabolism in the rat by dexamethasone
The antitumor drug taxol was metabolized to two major metabolites (RM1 and RM2) in adult male and female rat liver microsomes. The male rats produced RM1 2.6 fold faster than the females, and they produced RM2 3 fold faster than the females. This correlated well with the sex differences noticed in liver microsomal cytochrome P450 (CYP) 3A content (4.4 fold greater in male) and 6{beta}-hydroxylation of testosterone (2.4 fold greater in male). Taxol was metabolized to three major metabolites (RM1, RM2, and RM3) in adult male and female rat liver microsomes from rats pretreated with dexamethasone. Production of RM1 and RM2 was increased in these rats (2.3 and 3.3 fold respectively in males; 6.5 and 8.7 fold respectively in females) as compared to the untreated rats. These results compared well with the induction of CYP 3A proteins (3.5 fold in male, 10 fold in female) and induction of 6{beta}-hydroxylation (1.9 fold in males, 3.8 fold in females). RM3, which was produced only by the rats pretreated with dexamethasone, had a retention time of 0.58 relative to taxol which corresponds to 6{alpha}- hydroxytaxol, the major human metabolite of taxol. This study indicates that taxol metabolism in the rat is likely due to CYP 3A enzymes. Although the evidence points toward CYP 3A1 as the major isoform involved, it does not rule out others. The findings also suggest that CYP 3A1 is responsible for the induced metabolite, RM3.
- Research Organization:
- Medical Univ. of South Carolina, Charleston, SC (United States)
- OSTI ID:
- 121300
- Report Number(s):
- DOE/EW/50625--T25; ON: DE95016555; CNN: Grant CA63386; Grant FG01-912EW506
- Country of Publication:
- United States
- Language:
- English
Similar Records
Ethylbenzene exposure produces unique sex-related differences in cytochrome P-450 dependent activities
Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression
Metabolism of proposed nerve agent pretreatment, pyridostigmine bromide. Final report, December 1995-December 1996
Conference
·
Sun Mar 10 23:00:00 EST 1991
· FASEB Journal (Federation of American Societies for Experimental Biology); (United States)
·
OSTI ID:5265798
Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression
Journal Article
·
Thu Dec 14 23:00:00 EST 2006
· Toxicology and Applied Pharmacology
·
OSTI ID:20850509
Metabolism of proposed nerve agent pretreatment, pyridostigmine bromide. Final report, December 1995-December 1996
Technical Report
·
Sat Nov 30 23:00:00 EST 1996
·
OSTI ID:502657